Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Net Margin (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Net Margin for 5 consecutive years, with 4537.75% as the latest value for Q2 2025.

  • For Q2 2025, Net Margin fell 83557.0% year-over-year to 4537.75%; the TTM value through Dec 2025 reached 8522.65%, down 193128.0%, while the annual FY2023 figure was 1455.29%, N/A changed from the prior year.
  • Net Margin hit 4537.75% in Q2 2025 for Kezar Life Sciences, down from 4771.18% in the prior quarter.
  • Across five years, Net Margin topped out at 8938.36% in Q4 2021 and bottomed at 330.04% in Q3 2023.
  • Average Net Margin over 5 years is 5327.83%, with a median of 5682.8% recorded in 2022.
  • Year-over-year, Net Margin surged 36266bps in 2023 and then plummeted -94045bps in 2024.
  • Kezar Life Sciences' Net Margin stood at 8938.36% in 2021, then plummeted by -33bps to 5951.1% in 2022, then plummeted by -106bps to 330.04% in 2023, then surged by 1728bps to 5373.32% in 2024, then fell by -16bps to 4537.75% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 4537.75%, 4771.18%, and 5373.32% for Q2 2025, Q1 2025, and Q2 2024 respectively.